Methods to reduce postoperative surgical site infections after head and neck oncology surgery

The Lancet Oncology

Volumn 18, Issue 7, 2017, Pages e405-e413

  Cannon, Richard B ^a   Houlton, Jeffrey J ^a   Mendez, Eduardo ^a   Futran, Neal D ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFAZOLIN; CEFONICID; CEFOPERAZONE; CEFOTAXIME; CLINDAMYCIN; CLINDAMYCIN PLUS GENTAMICIN; LATAMOXEF; MOXIFLOXACIN; SULTAMICILLIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT;

AGE; ALBUMIN BLOOD LEVEL; AMERICAN SOCIETY OF ANESTHESIOLOGISTS; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BODY MASS; CANCER RADIOTHERAPY; CANCER SURGERY; COMORBIDITY; DIABETES MELLITUS; FREE TISSUE GRAFT; HEAD AND NECK CANCER; HEAD AND NECK SURGERY; HUMAN; HYPOTHYROIDISM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROSURGERY; MYOCUTANEOUS FLAP; NUTRITIONAL STATUS; OPERATION DURATION; OPERATIVE BLOOD LOSS; OVERALL SURVIVAL; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOKING; SURGICAL INFECTION; TOBACCO USE; TREATMENT FAILURE; HEAD AND NECK NEOPLASMS; RECONSTRUCTIVE SURGERY; SURGICAL FLAPS; SURGICAL WOUND INFECTION; VASCULARIZATION;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CLINDAMYCIN; HEAD AND NECK NEOPLASMS; HUMANS; RECONSTRUCTIVE SURGICAL PROCEDURES; RISK FACTORS; SURGICAL FLAPS; SURGICAL WOUND INFECTION;

EID: 85029668183     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(17)30375-3     Document Type: Review

References (84)

1. Centers for Disease Control and Prevention. Surgical site infection (SSI) event. http://www.cdc.gov/nhsn/pdfs/pscmanual/9pscssicurrent.pdf, January, 2016 (accessed Oct 1, 2016).
2. Suh, JK, Sercarz, JA, Abemayor, E, et al. Analysis of outcome and complications in 400 cases of microvascular head and neck reconstruction. Arch Otolaryngol Head Neck Surg 130 (2004), 962–966.
3. Jones, NF, Jarrahy, R, Song, JI, Kaufman, MR, Markowitz, B, Postoperative medical complications—not microsurgical complications—negatively influence the morbidity, mortality, and true costs after microsurgical reconstruction for head and neck cancer. Plast Reconstr Surg 119 (2007), 2053–2060.
4. Benatar, MJ, Dassonville, O, Chamorey, E, et al. Impact of preoperative radiotherapy on head and neck free flap reconstruction: a report on 429 cases. J Plast Reconstr Aesthet Surg 66 (2013), 478–482.
5. Dassonville, O, Poissonnet, G, Chamorey, E, et al. Head and neck reconstruction with free flaps: a report on 213 cases. Eur Arch Otorhinolaryngol 265 (2008), 85–95.
6. Halle, M, Bodin, I, Tornvall, P, Wickman, M, Farnebo, F, Arnander, C, Timing of radiotherapy in head and neck free flap reconstruction— a study of postoperative complications. J Plast Reconstr Aesthet Surg 62 (2009), 889–895.
7. Karakida, K, Aoki, T, Ota, Y, et al. Analysis of risk factors for surgical-site infections in 276 oral cancer surgeries with microvascular free-flap reconstructions at a single university hospital. J Infect Chemother 16 (2010), 334–339.
8. Bourget, A, Chang, JT, Wu, DB, Chang, CJ, Wei, FC, Free flap reconstruction in the head and neck region following radiotherapy: a cohort study identifying negative outcome predictors. Plast Reconstr Surg 127 (2011), 1901–1908.
9. Lee, DH, Kim, SY, Nam, SY, Choi, SH, Choi, JW, Roh, JL, Risk factors of surgical site infection in patients undergoing major oncological sugery for head and neck cancer. Oral Oncol 47 (2011), 528–531.
10. Shuman, AG, Shuman, EK, Hauff, SJ, et al. Preoperative topical antimicrobial decolonization in head and neck surgery. Laryngoscope 122 (2012), 2454–2460.
11. Mucke, T, Loeffelbein, DJ, Kolk, A, et al. Comparison of outcome of microvascular bony head and neck reconstructions using the fibular free flap and the iliac crest flap. Br J Oral Maxillofac Surg 51 (2013), 514–519.
12. Yang, CH, Chew, KY, Solomkin, JS, Lin, PY, Chiang, YC, Kuo, YR, Surgical site infections among high-risk patients in clean-contaminated head and neck reconstructive surgery: concordance with preoperative oral flora. Ann Plast Surg 71:suppl 1 (2013), S55–S60.
13. Kamizono, K, Sakuraba, M, Nagamatsu, S, Miyamoto, S, Hayashi, R, Statistical analysis of surgical site infection after head and neck reconstructive surgery. Ann Surg Oncol 21 (2014), 1700–1705.
14. Durand, ML, Yarlagadda, BB, Rich, DL, et al. The time course and microbiology of surgical site infections after head and neck free flap surgery. Laryngoscope 125 (2015), 1084–1089.
15. Yarlagadda, BB, Deschler, DG, Rich, DL, et al. Head and neck free flap surgical site infections in the ear of the Surgical Care Improvement Project. Head Neck 38:suppl 1 (2016), E392–E398.
16. Mitchell, RM, Mendez, E, Schmitt, NC, Bhrany, AD, Futran, ND, Antibiotic prophylaxis in patients undergoing head and neck free flap reconstruction. JAMA Otolaryngol Head Neck Surg 141 (2015), 1096–1103.
17. Cohen, LE, Finnerty, BM, Golas, AR, et al. Perioperative antibiotics in the setting of oropharyngeal reconstruction: less is more. Ann Plast Surg 76 (2016), 663–667.
18. Pool, C, Kass, J, Spivack, J, et al. Increased surgical site infection rates following clindamycin use in head and neck free tissue transfer. Otolaryngol Head Neck Surg 154 (2016), 272–278.
19. Khariwala, SS, Le, B, Pierce, BH, Vogel, RI, Chipman, JG, Antibiotic use after free tissue reconstruction of head and neck defects: short course vs long course. Surg Infect (Larchmt) 17 (2016), 100–105.
20. Danan, D, Shonka, DC, Selman, Y, Chow, Z, Smolkin, ME, Jameson, MJ, Prognostic value of albumin in patients with head and neck cancer. Laryngoscope 126 (2016), 1567–1571.
21. Bharadwaj, S, Trivax, B, Tandon, P, Alkam, B, Hanouneh, I, Steiger, E, Should perioperative immunonutrition for elective surgery be the current standard of care?. Gastroenterol Rep (Oxf) 4 (2016), 87–95.
22. Drover, JW, Dhaliwal, R, Weitzel, L, Wischmeyer, PE, Ochoa, JB, Heyland, DK, Perioperative use of arginine-supplemented diets: a systemic review of the evidence. J Am Coll Surg 212 (2011), 385–399.
23. Waitzberg, DL, Saito, H, Plank, LD, et al. Postsurgical infections are reduced with specialized nutrition support. World J Surg 30 (2006), 1592–1604.
24. Marik, PE, Zaloga, GP, Immunonutrition in high risk surgical patients: a systematic review and analysis of the literature. JPEN J Parenter Enterol Nutr 34 (2010), 378–386.
25. Lee, YK, Park, KY, Koo, YT, et al. Analysis of multiple risk factors affecting the result of free flap transfer for necrotising soft tissue defects of the lower extremities in patients with type 2 diabetes mellitus. J Plast Reconstr Aesthet Surg 67 (2014), 624–628.
26. Cannady, SB, Hatten, KM, Bur, Am, et al. Use of free tissue transfer in head and neck cancer surgery and risk of overall and serious complication(s): an American College of Surgeons-National Surgical Quality Improvement Project analysis of free tissue transfer to the head and neck. Head Neck 39 (2017), 702–707.
27. Lo, SL, Yen, YH, Lee, PJ, Liu, CC, Pu, CM, Factors influencing postoperative complications in reconstructive microsurgery for head and neck cancer. J Oral Maxillofac Surg 75 (2017), 867–873.
28. Liu, Z, Tian, Z, Zhang, C, Sun, J, Zhang, Z, He, Y, Microvascular reconstruction in elderly oral cavity cancer patients: does diabetes status have a predictive role in free flap complications?. J Oral Maxillofac Surg 73 (2015), 357–369.
29. Carniol, ET, Marchiano, E, Brady, JS, et al. Head and neck microvascular free flap reconstruction: an analysis of unplanned readmissions. Laryngoscope 127 (2017), 325–330.
30. Ishimaru, M, Ono, S, Suzuki, S, Matsui, H, Fushimi, K, Yasunaga, H, Risk factors for free flap failure in 2846 patients with head and neck cancer: a national database study in Japan. J Oral Maxillofac Surg 74 (2016), 1265–1270.
31. Johnson, JT, Wagner, RL, Infection following uncontaminated head and neck surgery. Arch Otolaryngol Head Neck Surg 113 (1987), 368–369.
32. Becker, GD, Parell, GJ, Cefazolin prophylaxis in head and neck cancer surgery. Ann Otol Rhinol Laryngol 88 (1979), 183–186.
33. Seagle, MB, Duberstein, LE, Gross, CW, Fletcher, JL, Mustafa, AQ, Efficacy of cefazolin as a prophylactic antibiotic in head and neck surgery. Otolaryngology, 86, 1978 ORL-568-72.
34. Johnson, JT, Yu, LV, Myers, EN, Muder, RR, Thearle, PB, Diven, WF, Efficacy of two third-generation cephalosporins in prophylaxis for head and neck surgery. Arch Otolaryngol 110 (1984), 224–227.
35. Koshkareva, YA, Johnson, JT, What is the perioperative antibiotic prophylaxis in adult oncologic head and neck surgery?. Laryngoscope 124 (2014), 1055–1056.
36. Russell, MD, Goldberg, AN, What is the evidence for use of antibiotic prophylaxis in clean-contaminated head and neck surgery?. Laryngoscope 122 (2012), 945–946.
37. Johnson, JT, Myers, EN, Thearle, PB, Sigler, BA, Schramm, VL, Antimicrobial prophylaxis for contaminated head and neck surgery. Laryngoscope 94 (1984), 46–51.
38. Johnson, JT, Yu, VL, Myers, EN, Wagner, RL, Sigler, BA, Cefazolin vs moxalactam? A double blind randomized trial of cephalosporins in head and neck surgery. Arch Otolaryngol Head Neck Surg 112 (1986), 151–153.
39. Johnson, JT, Yu, VL, Myers, EN, Wagner, RL, An assessment of need for gram-negative bacterial coverage in antibiotic prophylaxis for oncological head and neck surgery. J Infect Dis 155 (1987), 331–333.
40. Johnson, JT, Schuller, DE, Silver, F, et al. Antibiotic prophylaxis in high-risk head and neck surgery: one-day vs five-day therapy. Otolaryngol Head Neck Surg 95 (1986), 554–557.
41. Johnson, JT, Yu, VL, Antibiotic use during major head and neck surgery. Ann Surg 207 (1988), 108–111.
42. Weber, RS, Raad, I, Frankenthaler, R, et al. Ampicillin-subactam vs clindamycin in head and neck oncologic surgery. The need for gram-negative coverage. Arch Otolaryngol Head Neck Surg 118 (1992), 1159–1163.
43. Righi, M, Manfredi, R, Farneti, G, Pasquini, E, Cenacchi, V, Short-term versus long-term antimicrobial prophylaxis in oncologic head and neck surgery. Head Neck 18 (1996), 399–404.
44. Johnson, JT, Kachman, K, Wagner, RL, Myers, EN, Comparison of ampicillin-sulbactam versus clindamycin in the prevention of infection in patients undergoing head and neck surgery. Head Neck 19 (1997), 367–741.
45. Carroll, WR, Rosenstiel, D, Fix, JR, et al. Three-dose vs extended-course clindamycin prophylaxis for free-flap reconstruction of the head and neck. Arch Otolaryngol Head Neck Surg 129 (2003), 771–774.
46. Skitarelić N, Morovic, M, Manestar, D, Antibiotic prophylaxis in clean-contaminated head and neck oncological surgery. J Craniomaxillofac Surg 35 (2007), 15–20.
47. Liu, SA, Tung, KC, Shiao, JY, Chiu, YT, Preliminary report of associated factors in surgical site infection after major head and neck neoplasm operations—does the duration of prophylactic antibiotics matter?. J Laryngol Otol 122 (2008), 403–408.
48. Sepehr, A, Santos, BJ, Chou, C, et al. Antibiotics and head and neck surgery in the setting of malnutrition, tracheotomy, and diabetes. Laryngoscope 119 (2009), 549–553.
49. Mücke, T, Rohleder, NH, Rau, A, et al. The value of perioperative antibiotics on the success of oral free flap reconstructions. Microsurgery 35 (2015), 507–511.
50. Langerman, A, Ham, SA, Pisano, J, Pariser, J, Hohmann, SF, Meltzer, DO, Laryngectomy complications are associated with perioperative antibiotic choice. Otolaryngol Head Neck Surg 153 (2015), 60–68.
51. Langerman, A, Thisted, R, Hohmann, S, Howell, M, Antibiotic and duration of perioperative prophylaxis predicts surgical site infection in head and neck surgery. Otolaryngol Head Neck Surg 154 (2016), 1054–1063.
52. Zevallos, JP, An administrative data approach to examining perioperative antibiotic use in head and neck oncologic surgery. Otolaryngol Head Neck Surg 153 (2015), 69–70.
53. Cannon, RB, Sowder, JC, Buchmann, LO, et al. Increasing use of nonsurgical therapy in advanced-stage oral cavity cancer: a population-based study. Head Neck 39 (2017), 82–91.
54. Gourin, CG, Frick, KD, Effect of surgeon and hospital volume on short-term outcomes and cost of care. Laryngoscope 122 (2012), 88–94.
55. Ganly, I, Patel, S, Matsuo, J, et al. Postoperative complications of salvage total laryngectomy. Cancer 103 (2005), 2073–2081.
56. Gil, Z, Gupta, A, Kummer, B, et al. The role of pectoralis major muscle flap in salvage total laryngectomy. Arch Otolaryngol Head Neck Surg 135 (2009), 1019–1023.
57. Sowder, JC, Cannon, RB, Buchmann, LO, et al. Treatment-related determinants of survival in early-stage (T1-2N0M0) oral cavity cancer: a population-based study. Head Neck 39 (2017), 876–880.
58. Paleri, V, Drinnan, M, van den Brekel, MW, et al. Vascularized tissue to reduce fistula following salvage total laryngectomy: a systematic review. Laryngoscope 124 (2014), 1848–1853.
59. Sayles, M, Grant, DG, Preventing pharyngo-cutaneous fistula in total laryngectomy: a systematic review and meta-analysis. Laryngoscope 124 (2014), 1150–1163.
60. Dedivitis, RA, Aires, FT, Cernea, CR, Brandao, LG, Pharyngocutaneous fistula after total laryngectomy: systematic review of risk factors. Head Neck 37 (2015), 1691–1697.
61. Guimarães, Aires, FT, Dedivitis, RA, et al. Efficacy of pectoralis major muscle flap for pharyngocutaneous fistula prevention in salvage total laryngectomy: a systematic review. Head Neck 38:suppl 1 (2016), E2317–E2321.
62. Righini, C, Lequeux, T, Cuisnier, O, Morel, N, Reyt, E, The pectoralis myofascial flap in pharyngolaryngeal surgery after radiotherapy. Eur Arch Otorhinolaryngol 262 (2005), 357–361.
63. Patel, UA, Keni, SP, Pectoralis myofascial flap during salvage laryngectomy prevents pharyngocutaneous fistula. Otolaryngol Head Neck Surg 141 (2009), 190–195.
64. Oosthuizen, JC, Leonard, DS, Kinsella, JB, The role of pectoralis major myofascial flap in salvage laryngectomy: a single surgeon experience. Acta Otolaryngol 132 (2012), 1002–1005.
65. Sakai, A, Okami, K, Sugimoto, R, et al. Prevention of wound complications in salvage pharyngolaryngectomy by the use of well-vascularized flaps. Acta Otolaryngol 132 (2012), 778–782.
66. Sousa, AA, Castro, SM, Pocaro-Salles, JM, et al. The usefulness of a pectoralis major myocutaneous flap in preventing salivary fistulae after salvage total laryngectomy. Braz J Otorhinolaryngol 78 (2012), 103–107.
67. Patel, UA, More, BA, Wax, M, et al. Impact of pharyngeal closure technique on fistula after salvage laryngectomy. JAMA Otolaryngol Head Neck Surg 139 (2013), 1156–1162.
68. Cömert, E, Tunçel, Ü Torun, MT, et al. Pectoralis major myofascial flap in salvage laryngectomy. J Laryngol Otol 128 (2014), 714–719.
69. Sayles, M, Koonce, SL, Harrison, L, Beasley, N, McRae, AR, Grant, DG, Pharyngo-cutaneous fistula complicating laryngectomy in the chemoradiotherapy organ-preservation epoch. Eur Arch Otorhinolaryngol 271 (2014), 1765–1769.
70. Gilbert, MR, Sturm, JJ, Gooding, WE, Johnson, JT, Kim, S, Pectoralis major myofascial onlay and myocutaneous flaps and pharyngocutaneous fistula in salvage laryngectomy. Laryngoscope 124 (2014), 2680–2686.
71. Gendreau-Lefèvre, AK, Audet, N, Maltais, S, Thuot, F, Prophylactic pectoralis major muscle flap in prevention of pharyngocutaneous fistula in total laryngectomy after radiotherapy. Head Neck 37 (2015), 1233–1238.
72. Rothmeier, N, Bergmann, C, Mattheis, S, Weller, P, Lang, S, The primary use of pectoralis myofascial flap in salvage laryngectomy. Laryngorhinootologie 94 (2015), 232–238.
73. Fung, K, Teknos, TN, Vandenberg, CD, et al. Prevention of wound complications following salvage laryngectomy using free vascularized tissue. Head Neck 29 (2007), 425–430.
74. Belusic-Gobic, M, Car, M, Juretic, M, Cerovic, R, Gobic, D, Golubovic, V, Risk factors for wound infection after oral cancer surgery. Oral Oncol 43 (2007), 77–81.
75. Cilento, BW, Izzard, M, Weymuller, EA, Futran, NF, Comparison of approaches for oral cavity cancer resection: lip-split versus visor flap. Otolaryngol Head Neck Surg 137 (2007), 428–432.
76. Hanasono, MM, Lin, D, Wax, MK, Rosenthal, EL, Closure of laryngectomy defects in the age of chemoradiation therapy. Head Neck 34 (2012), 580–588.
77. Hui, Y, Wei, WI, Yuen, PW, Lam, LK, Ho, WK, Primary closure of pharyngeal remnant after total laryngectomy and partial pharyngectomy: how much residual mucosa is sufficient?. Laryngoscope 106 (1996), 490–494.
78. Lee, DH, Kim, SY, Nam, SY, Choi, SH, Choi, JW, Roh, JL, Risk factors of surgical site infection in patients undergoing major oncological surgery for head and neck cancer. Oral Oncology 47 (2011), 528–531.
79. Goyal, N, Emerick, KS, Deschler, DG, et al. Risk factors for surgical site infection after supraclavicular flap reconstruction in patients undergoing major head and neck surgery. Head Neck 38 (2016), 1615–1620.
80. Howard, BE, Nagel, TH, Donald, CB, Hinni, ML, Hayden, RE, Oncologic safety of the submental flap for reconstruction in oral cavity malignancies. Otolaryngol Head Neck Surg 150 (2014), 558–562.
81. Choi, S, Schwartz, DL, Farwell, G, Austin-Seymour, M, Futran, ND, Radiation therapy does not impact local complication rates after free flap reconstruction for head and neck cancer. Arch Otolaryngol Head Neck Surg 130 (2004), 1308–1312.
82. Hsieh, TY, Chang, KP, Lee, SS, et al. Free flap reconstruction in patients with advanced oral squamous cell carcinoma: analysis of patient survival and cancer recurrence. Microsurgery 32 (2012), 598–604.
83. Tsue, TT, Desyatnikova, SS, Deleyiannis, FWB, et al. Comparison of cost and function in reconstruction of the posterior oral cavity and oropharynx. Arch Otolaryngol Head Neck Surg 123 (1997), 731–737.
84. Canis, M, Weiss, BG, Ihler, F, Hummers-Pradier, E, Matthias, C, Wolff, HA, Quality of life in patients after resection of pT3 lateral tongue carcinoma: microvascular reconstruction versus primary closure. Head Neck 38 (2016), 89–94.